Yep. Strategy clear. Need to understand that FDA approving stem cells (ahem...mesenchymal precursor cells MPCs) is politically contentious, irrespective of dead patients. FDA is a regulatory institution vibrating at the convergence of seppo politics, science, & vested interest, and MSB is ideal as an antipodean interloper agent smuggling new science into this realm to progress best disruptive SOC based on power of pluripotent cells modulating archaic defence systems in a paradigm shift within medical science.
2024 will be the MSB annus cardio, calor, dolor, rubor, tumor and (Lightner) anus. Even if she is playing for the opposition team on extracellular vesicles. Go MSB.
banter and General Discussion, page-9108
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.025(2.22%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.19 | $1.13 | $8.289M | 7.186M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22569 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 105374 | 2 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.025 ( 2.46 %) |
||||
| Open | High | Low | Volume | ||
| $1.16 | $1.19 | $1.13 | 1229288 | ||
| Last updated 15.59pm 22/05/2024 ? | |||||
| MSB (ASX) Chart |